mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.03 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.04 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.04 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |